Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Minerva Neuroscie (NQ: NERV ) 3.140 -0.080 (-2.48%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 10,478 Open 3.220 Bid (Size) 3.140 (15) Ask (Size) 3.170 (1) Prev. Close 3.220 Today's Range 3.125 - 3.380 52wk Range 2.260 - 13.49 Shares Outstanding 6,993,406 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News NERV Stock Earnings: Minerva Neurosciences Beats EPS for Q1 2024 May 01, 2024 NERV stock results show that Minerva Neurosciences beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates May 01, 2024 From Minerva Neurosciences, Inc Via GlobeNewswire Performance YTD -48.94% -48.94% 1 Month -8.72% -8.72% 3 Month +26.61% +26.61% 6 Month -58.30% -58.30% 1 Year -66.05% -66.05% More News Read More Dow Dips Over 100 Points; J.M. Smucker Posts Upbeat Earnings February 27, 2024 Via Benzinga Topics Stocks Exposures US Equities Regulatory Setback For Minerva Neurosciences' Schizophrenia Treatment Candidate, FDA Asks For More Data February 27, 2024 Via Benzinga Exposures Product Safety Minerva Neurosciences: Q4 Earnings Insights February 22, 2024 Via Benzinga Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session February 27, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session February 27, 2024 Via Benzinga Crude Oil Gains 1%; Macy's Plans To Close 150 Stores February 27, 2024 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Nasdaq Rises 50 Points; Lowe's Earnings Top Views February 27, 2024 Via Benzinga Topics Stocks Exposures US Equities Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia February 27, 2024 From Minerva Neurosciences, Inc Via GlobeNewswire Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates February 22, 2024 From Minerva Neurosciences, Inc Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Intraday Session February 08, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session February 05, 2024 Via Benzinga Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates November 07, 2023 From Minerva Neurosciences, Inc Via GlobeNewswire Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates August 01, 2023 From Minerva Neurosciences, Inc Via GlobeNewswire 10 Short Squeeze Stocks To Watch: Baosheng Media, Toro Corp, Getty Images And More July 18, 2023 Via Benzinga Top 5 Health Care Stocks That May Collapse This Quarter July 10, 2023 Via Benzinga Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet June 30, 2023 Via Benzinga Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 29, 2023 Via Benzinga BioXcel Therapeutics, Alvotech And Other Big Stocks Moving Lower On Thursday June 29, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session June 29, 2023 Via Benzinga Why CorMedix Are Trading Lower By 22%; Here Are 20 Stocks Moving Premarket June 29, 2023 Via Benzinga Crude Oil Rises Sharply; Unifirst Earnings Miss Expectations June 28, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session June 28, 2023 Via Benzinga Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session June 28, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.